| PDF (1MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-314220
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.31422
Zusammenfassung
the underlying aneurysm leading to decrease of immediate complications such as rebleeding, cerebral vasospasm remains the major cause for mortality and morbidity after subarachnoid hemorrhage. The only FDA approved drug for treatment of cerebral vasospasm is the calcium antagonist Nimodipine that has shown beneficial effects on outcome. It is safe, cost efficient and the most widely studied drug ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik